| abstract |
FIELD: medicine. ^ SUBSTANCE: invention claims antibodies, which specifically bind with IL-13. Also claimed are nucleic acids, encoding antibodies, expression vectors, containing sequences of said nucleic acids, as well as cells, containing such cells. In addition claimed is method of diagnosing associated with IL-13 disorders, method of obtaining molecule of recombinant antibody, method of treating disorder, associated with IL-13 activity, method of determining IL-13 in sample and method of treating subject, demonstrating asthma attack. ^ EFFECT: invention can be efficiently applied in diagnostics and treatment of IL-13 mediated disorders. ^ 116 cl, 16 dwg, 4 tbl, 21 ex |